Aptorum Group Ltd Class A
Biotechnology
Healthcare
APM
5.18 M shares
NASDAQ US
traded
11 Feb 2025
listed
no
open
1.67
52 week high
4.53
high
1.67
52 week low
0.55
low
1.30
growth
-64.27 %
previous Close
1.33
P/E ratio
-1
market cap
6.06 M
div yield
0
usd
Mar 2023
qoq
revenue
768 K
45.68 %
net incoming
-7.91 M
-319.80 %
eps
-2.22 %
-4.00 %
eps surprise
0.00 %
net profit margin
-1029.94 %
-672.00 %
operating incoming
-9.06 M
-7.17 %
net change in cash
-2.18 M
-104.91 %
cash on hand
1.88 M
-53.70 %
cost of revenue
1.31 M
17.79 %
top top